Answers are grounded in this paper and cite their sources.
Non-interventional study shows low guideline-directed therapy in heart failure with reduced ejection fraction, suggesting need for better management in Central Eastern Europe.
This large non-interventional study provides a contemporary perspective of the treatments used in HFrEF over 1-year follow-up. Despite high dapagliflozin persistence rates, a low proportion of patients received complete guideline-directed medical therapy in optimal doses. Improvement of HF management decisions across the CEE-BA region is warranted.
No takes yet. Share an insight, caveat, or question.
Leszek et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: